UBS Group’s IPATH INVERSE S&P 500 VIX SHORT-TERM FUTURES ETN XXV Stock Holding History

UBS Group’s Portfolio XXV Stock Details XXV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-238	Closed	-$9K	–	8676
2018 Q1	$9K	Buy	+238	New	+$8.99K	﹤0.01%	6984
2016 Q4	–	Sell	-457	Closed	-$13K	–	8485
2016 Q3	$13K	Hold	457	–	–	﹤0.01%	6641
2016 Q2	$17K	Sell	457 -650	-59%	-$24.3K	﹤0.01%	6443
2016 Q1	$42K	Sell	1,107 -480	-30%	-$18.3K	﹤0.01%	5642
2015 Q4	$60K	Hold	1,587	–	–	﹤0.01%	5674
2015 Q3	$60K	Sell	1,587 -1,000	-39%	-$38.2K	﹤0.01%	5675
2015 Q2	$99K	Sell	2,587 -1,500	-37%	-$57.4K	﹤0.01%	5419
2015 Q1	$156K	Sell	4,087 -343	-8%	-$13.1K	﹤0.01%	5078
2014 Q4	$170K	Buy	+4,430	New	+$170K	﹤0.01%	5196

UBS Group's XXV Position: Q2 2018 in Review

UBS Group sold out of IPATH INVERSE S&P 500 VIX SHORT-TERM FUTURES ETN (XXV) in Q2 2018, closing a stake of 238 shares — an estimated $9K sold.

UBS Group first reported a position in XXV in Q4 2014 and held it in 9 quarters. The position peaked at $170K in Q4 2014. 0 funds tracked by Wall St. Rank hold XXV as of Q2 2018.

UBS Group reported no remaining IPATH INVERSE S&P 500 VIX SHORT-TERM FUTURES ETN position as of Q2 2018 after selling out during the quarter.
UBS Group sold 238 IPATH INVERSE S&P 500 VIX SHORT-TERM FUTURES ETN shares in Q2 2018, an estimated $9K.
UBS Group first reported a position in IPATH INVERSE S&P 500 VIX SHORT-TERM FUTURES ETN in Q4 2014 and held it in 9 quarters.
UBS Group's IPATH INVERSE S&P 500 VIX SHORT-TERM FUTURES ETN position peaked at $170K in Q4 2014.
0 funds tracked by Wall St. Rank held IPATH INVERSE S&P 500 VIX SHORT-TERM FUTURES ETN as of Q2 2018.

Based on UBS Group's 13F filing for Q2 2018, filed 14 Aug 2018.